I am a M.D., PhD. (Universidad de la República, Uruguay) with a postdoctoral degree in pharmacology and chemical biology (Department of Pharmacology, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA). Upon returning to Uruguay (2007-2013) I began working as co-head of the Analytical Biochemistry and Proteomics Unit, one of the first units to acquire state-of-the-art mass spectrometers in South America. Later, I developed my own laboratory: Lab. of Vascular Biology and Drug Discovery.  The Lab. of Vascular Biology and Drug Discovery has been focused on understanding the molecular and cellular basis of cardiovascular and metabolic diseases (e.g., atherosclerosis, metabolic syndrome, obesity, hypertension) as well as in the development of novel strategies for the prevention and treatment of these leading cause of death worldwide. We founded a startup (EOLO Pharma inc., USA) with the aim of being able to take the discoveries from the laboratory to clinical trials in humans.

‍